Abstract
The morphology of dendritic spines is highly correlated with the neuron function. Therefore, it is of positive influence for the research of the dendritic spines. However, it is tried to manually label the spine types for statistical analysis. In this work, we proposed an approach based on the combination of wavelet contour analysis for the backbone detection, wavelet packet entropy, and fuzzy support vector machine for the spine classification. The experiments show that this approach is promising. The average detection accuracy of “MushRoom” achieves 97.3%, “Stubby” achieves 94.6%, and “Thin” achieves 97.2%.
Keywords: Dendritic spines, discrete wavelet transform, fuzzy support vector machine, wavelet packet entropy.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Detection of Dendritic Spines Using Wavelet Packet Entropy and Fuzzy Support Vector Machine
Volume: 16 Issue: 2
Author(s): Shuihua Wang, Yang Li, Ying Shao, Carlo Cattani, Yudong Zhang and Sidan Du
Affiliation:
Keywords: Dendritic spines, discrete wavelet transform, fuzzy support vector machine, wavelet packet entropy.
Abstract: The morphology of dendritic spines is highly correlated with the neuron function. Therefore, it is of positive influence for the research of the dendritic spines. However, it is tried to manually label the spine types for statistical analysis. In this work, we proposed an approach based on the combination of wavelet contour analysis for the backbone detection, wavelet packet entropy, and fuzzy support vector machine for the spine classification. The experiments show that this approach is promising. The average detection accuracy of “MushRoom” achieves 97.3%, “Stubby” achieves 94.6%, and “Thin” achieves 97.2%.
Export Options
About this article
Cite this article as:
Wang Shuihua, Li Yang, Shao Ying, Cattani Carlo, Zhang Yudong and Du Sidan, Detection of Dendritic Spines Using Wavelet Packet Entropy and Fuzzy Support Vector Machine, CNS & Neurological Disorders - Drug Targets 2017; 16 (2) . https://dx.doi.org/10.2174/1871527315666161111123638
DOI https://dx.doi.org/10.2174/1871527315666161111123638 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drusen in the Peripheral Retina of the Alzheimer’s Eye
Current Alzheimer Research The Problem in Translating French into English: Can we Translate the Style?
Neuroscience and Biomedical Engineering (Discontinued) Pharmacological Inhibition of PKR in APPswePS1dE9 Mice Transiently Prevents Inflammation at 12 Months of Age but Increases Aβ42 Levels in the Late Stages of the Alzheimer’s Disease
Current Alzheimer Research Neuropathic Pain and Lung Delivery of Nanoparticulate Drugs: An Emerging Novel Therapeutic Strategy
CNS & Neurological Disorders - Drug Targets Buprenorphine and Methadone Maintenance Treatment - Sexual Behaviour and Dysfunction Prevalence
Letters in Drug Design & Discovery Rationale for Peptide and DNA Based Epitope Vaccines for Alzheimers Disease Immunotherapy
CNS & Neurological Disorders - Drug Targets Astrocytic Expression of the Immunoreceptor CD300f Protects Hippocampal Neurons from Amyloid-β Oligomer Toxicity In Vitro
Current Alzheimer Research Meet Our Editorial Board Member
Current Drug Safety Glutathione Peroxidase: A Potential Marker for the Most Common Diseases and Disorders
Recent Patents on Biomarkers Neurodegenerative Pathways in Parkinsons Disease: Therapeutic Strategies
Current Drug Targets - CNS & Neurological Disorders Zinc-mediated Neurotransmission in Alzheimer's Disease: A Potential Role of the GPR39 in Dementia
Current Neuropharmacology Activation of Human Platelets by 2-Arachidonoylglycerol: Role of PKC in NO/cGMP Pathway Modulation
Current Neurovascular Research Selective Targeting of Muscarinic Receptors: Novel Therapeutic Approaches for Psychotic Disorders
Current Neuropharmacology Methods for Hydroxamic Acid Synthesis
Current Organic Chemistry Therapeutic Strategies in Autoimmune Diseases by Interfering with Leukocyte Endothelium Interaction
Current Pharmaceutical Design Genome-Scale Technologies Foster Advances in Neurological and Behavioral Research
Current Psychiatry Reviews An Overview of Parkinsons Disease and the Cannabinoid System and Possible Benefits of Cannabinoid-Based Treatments
Current Medicinal Chemistry Pharmacology of Sigma (σ) Receptor Ligands from a Behavioral Perspective
Current Pharmaceutical Design AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models
Current Alzheimer Research Patent Selections
Recent Patents on Anti-Infective Drug Discovery